Kaplan–Meier survival analysis using the clinical genomic datasets demonstrated that high levels of PRDM1 levels are significantly associated with bad prognosis in the CRC patients (Fig. 1a). The gene discussed is PRDM1; the disease is colorectal carcinoma.